Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study

Journal of the American Society of Nephrology

Volumn 16, Issue 6, 2005, Pages 1788-1793

  Slinin, Yelena ^a   Foley, Robert N ^a,b   Collins, Allan J ^a,b  

^a United States Renal Data System   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; HEMODIALYSIS; HUMAN; INFORMATION PROCESSING; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES; AGED; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; FEMALE; MALE; METABOLIC DISORDER; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; CALCIUM; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC DISEASES; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 26944445097     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004040275     Document Type: Article

References (28)

1. Lazarus JM, Lowrie EG, Hampers CL, Merrill JP: Cardiovascular disease in uremic patients on hemodialysis. Kidney Int Suppl 167-175, 1975
2. Drueke T, Fauchet M, Fleury J, Lesourd P, Toure Y, Le Pailleur C, de Vernejoul P, Crosnier J: Effect of parathyroidectomy on left-ventricular function in haemodialysis patients. Lancet 1: 112-114, 1980
3. London GM, de Vernejoul MC, Fabiani F, Marchais SJ, Guerin AP, Metivier F, London AM, Llach F: Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients. Kidney Int 32: 900-907, 1987
4. Smogorzewski M, Zayed M, Zhang YB, Roe J, Massry SG: Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes. Am J Physiol 264: H1998-H2006, 1993
5. Amann K, Ritz E, Wiest G, Klaus G, Mall G: A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4: 1814-1819, 1994
6. Sato S, Ohta M, Kawaguchi Y, Okada H, Ono M, Saito H, Utsunomiya M, Tamura T, Sugimoto K, Takamizawa S: Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism. Miner Electrolyte Metab 21: 67-71, 1995
7. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K: Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61: 638-647, 2002
8. Chen NX, O'Neill KD, Duan D, Moe SM: Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 62: 1724-1731, 2002
9. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483, 2000
10. Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, Fukiyama K: Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 38: 64-69, 2001
11. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31: 607-617, 1998
12. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK: Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12: 2131-2138, 2001
13. Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62: 245-252, 2002
14. Bushinsky DA, Monk RD: Electrolyte quintet: Calcium. Lancet 352: 306-311, 1998
15. Brenner BM: The Kidney, 6th Ed., Philadelphia, W.B. Saunders Company, 2000
16. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004
17. Avram MM, Mittman N, Myint MM, Fein P: Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. Am J Kidney Dis 38: 1351-1357, 2001
18. Rostand SG, Drueke TB: Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56: 383-392, 1999
19. Massry SG, Smogorzewski M: Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia. Semin Nephrol 14: 219-231, 1994
20. Mazzaferro S, Coen G, Bandini S, Borgatti PP, Ciaccheri M, Diacinti D, Ferranti E, Lusenti T, Mancini G, Monducci I: Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus. Nephrol Dial Transplant 8: 335-340, 1993
21. Amann K, Ritz E: Cardiac disease in chronic uremia: Pathophysiology. Adv Renal Replace Ther 4: 212-224, 1997
22. Amann K, Tornig J, Flechtenmacher C, Nabokov A, Mall G, Ritz E: Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: Evidence for a permissive action of PTH. Nephrol Dial Transplant 10: 2043-2048, 1995
23. Kosch M, Hausberg M, Vormbrock K, Kisters K, Gabriels G, Rahn KH, Barenbrock M: Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res 47: 813-818, 2000
24. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731-1740, 2003
25. Perneger TV, Klag MJ, Whelton PK: Cause of death in patients with end-stage renal disease: Death certificates vs registry reports. Am J Public Health 83: 1735-1738, 1993
26. Jollis JG, Ancukiewicz M, DeLong ER, Pryor DB, Muhlbaier LH, Mark DB: Discordance of databases designed for claims payment versus clinical information systems. Implications for outcomes research. Ann Intern Med 119: 844-850, 1993
27. Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr: Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 27: 699-703, 2004
28. Locatelli F, Cannata-Andia JB, Drueke TB, Horl WH, Fouque D, Heimburger O, Ritz E: Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant 17: 723-731, 2002